Vitamin C Deficiency in Critically Ill Children: Prospective Observational Cohort Study

Alireza Fathi1,2, Corcoran Downey1, Aida Rabiee Gohar2

  • 1Pediatric Critical Care Unit, Miller Children's & Women's Hospital Long Beach, Long Beach, CA.

Insights

Vitamin C deficiency is common in critically ill children admitted to the pediatric intensive care unit (PICU). This study found 18% of PICU patients had a deficiency, compared to none in non-critical care patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Nutritional Science
  • Biochemistry

Background:

  • Vitamin C is essential for immune function and critical illness recovery.
  • Nutritional deficiencies can exacerbate outcomes in critically ill pediatric patients.
  • Data on vitamin C status in pediatric intensive care unit (PICU) populations is limited.

Purpose of the Study:

  • To determine the prevalence of vitamin C deficiency in critically ill children.
  • To compare vitamin C levels in critically ill children versus non-critically ill children undergoing sedation.

Main Methods:

  • A prospective observational cohort study was conducted at a single tertiary-care teaching hospital.
  • Two groups were studied: critically ill children in the PICU (n=60) and non-critically ill children undergoing elective outpatient procedures (n=21).
  • Vitamin C levels were measured within 24 hours of PICU admission and before sedation in the non-critical group.

Main Results:

  • Vitamin C deficiency was identified in 18% (11/60) of critically ill children in the PICU.
  • No vitamin C deficiency was observed in the non-critical care group (0/21).
  • The difference in vitamin C deficiency between the groups was statistically significant (p < 0.05).

Conclusions:

  • Vitamin C deficiency is prevalent in critically ill children admitted to the PICU.
  • These findings highlight the need for monitoring and potentially supplementing vitamin C in this vulnerable population.
  • Further research is warranted to explore the clinical impact and optimal management strategies for vitamin C deficiency in pediatric critical illness.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
1.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
110
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
394
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
218
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
351